AudioCure Pharma raised an undisclosed amount in a funding round led by InfectoPharm to advance the clinical development of the innovative drug candidate AC102 for sudden hearing loss.
Round Type
Funding Round
BerlinBiotechnologyHealth CareMedicalInvestors
Description
AudioCure Pharma, a Berlin-based start-up, secures new funding from InfectoPharm to support the development of AC102, a promising drug candidate for sudden hearing loss. The collaboration aims to enhance the clinical development and leverage the expertise of existing investors MED-EL and High-Tech Gründerfonds.
Who to call at AudioCure Pharma, and when
A new round usually means AudioCure Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AudioCure Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AudioCure Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AudioCure Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AudioCure Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AudioCure Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.